biopharma

Market Access

Applying intercultural intelligence to promote growth in the...

There are significant opportunities for pharma and biotech companies to support patients in the Middle East, but how do companies navigate such a culturally diverse region?

R&D

Clinical development rates are falling - but it’s not all ba...

Over the past decade, a shift has been occurring in biopharma R&D.

Digital

How is the rise of GenAI changing the field of pharma medica...

Pharma medical writing is an onerous, ongoing activity that could benefit hugely from tech-enabled disruption, and the latest advances in generative AI (GenAI) show promise in alleviating t

R&D

London’s life sciences scene upbeat as 2024 conference seaso...

With 2024 well under way, influential conferences in London have given a barometer reading on the conditions in the European biopharma market, reports Richard Staines.

Market Access

The 2024 biopharma M&A landscape: An overview

It’s been a couple of months since pharma’s annual JP Morgan Chase Healthcare Conference, where the mood around pharma M&A this year was optimistic, albeit with a few caveats.

R&D